Lantheus Holdings (LNTH) Net Cash Flow (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Net Cash Flow came in at $139.5 million in Q1 2026, up 444.33% year-on-year from $25.6 million in Q1 2025, and up 730.66% on a QoQ basis from -$22.1 million in Q4 2025.

Lantheus Holdings (LNTH) Net Cash Flow (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Net Cash Flow data on file, last reported at $139.5 million in Q1 2026.

  • On a quarterly basis, Net Cash Flow rose 444.33% year-over-year to $139.5 million in Q1 2026; TTM through Mar 2026 was -$439.7 million, a 298.12% decrease from a year earlier, with the FY2025 full-year figure at -$553.6 million, down 376.53% from the prior year.
  • Net Cash Flow for Q1 2026 stood at $139.5 million, up from -$22.1 million in the prior quarter.
  • Over the last five years, Net Cash Flow for LNTH reached as high as $200.1 million in Q3 2023 and fell as low as -$313.3 million in Q3 2025.
  • Historically, Net Cash Flow has averaged $23.6 million across 5 years, with a median of $47.5 million in 2024.
  • Across the five-year window, Net Cash Flow surged 43981.96% in 2022 and slumped 713.54% in 2025, its largest moves.
  • Year by year, Net Cash Flow stood at $158.5 million in 2022, then sank by 37.04% to $99.8 million in 2023, then sank by 52.42% to $47.5 million in 2024, then sank by 146.59% to -$22.1 million in 2025, then jumped by 730.66% to $139.5 million in 2026.
  • Per Business Quant data, the three most recent Net Cash Flow figures were $139.5 million in Q1 2026, -$22.1 million in Q4 2025, and -$313.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 202.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -526.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 711.50 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -277.40 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 461.90 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -446.50 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -112.00 Mn
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn 139.49 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 139.49 Mn
Mar 31, 2026 139.49 Mn
Dec 31, 2025 -22.12 Mn
Dec 31, 2025 -22.12 Mn
Sep 30, 2025 -313.34 Mn
Sep 30, 2025 -313.34 Mn
Jun 30, 2025 -243.78 Mn
Jun 30, 2025 -243.78 Mn
Mar 31, 2025 25.63 Mn
Mar 31, 2025 25.63 Mn
Dec 31, 2024 47.47 Mn
Dec 31, 2024 47.47 Mn
Sep 30, 2024 109.13 Mn
Sep 30, 2024 109.13 Mn
Jun 30, 2024 39.73 Mn
Jun 30, 2024 39.73 Mn
Mar 31, 2024 3.86 Mn
Mar 31, 2024 3.86 Mn
Dec 31, 2023 99.77 Mn
Dec 31, 2023 99.77 Mn